EA201992617A1 - Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения - Google Patents

Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения

Info

Publication number
EA201992617A1
EA201992617A1 EA201992617A EA201992617A EA201992617A1 EA 201992617 A1 EA201992617 A1 EA 201992617A1 EA 201992617 A EA201992617 A EA 201992617A EA 201992617 A EA201992617 A EA 201992617A EA 201992617 A1 EA201992617 A1 EA 201992617A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
radiation
reducing
exposure
modification
Prior art date
Application number
EA201992617A
Other languages
English (en)
Inventor
Джозеф Эдвард Шульц
Роджер Харт
Брент Велборн
Original Assignee
Амген Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк. filed Critical Амген Инк.
Publication of EA201992617A1 publication Critical patent/EA201992617A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/24—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Предложены способы инактивации вируса в образце, содержащем белковый компонент. Также предложены способы уменьшения разложения или модификации белка в присутствии реакционноспособных веществ, таких как реакционноспособные вещества, образующиеся в результате воздействия УФ-излучения. Согласно другому аспекту предложен способ уменьшения окисления остатков метионина, остатков триптофана либо и остатков метионина, и остатков триптофана в белке, подвергаемом воздействию УФ-излучения. Предложенные способы могут быть реализованы в любом масштабе и могут быть, если требуется, автоматизированы.
EA201992617A 2011-10-26 2012-10-25 Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения EA201992617A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161551822P 2011-10-26 2011-10-26

Publications (1)

Publication Number Publication Date
EA201992617A1 true EA201992617A1 (ru) 2020-03-10

Family

ID=47138200

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201490867A EA034347B1 (ru) 2011-10-26 2012-10-25 Способ инактивации вирусов при получении антител
EA201992617A EA201992617A1 (ru) 2011-10-26 2012-10-25 Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201490867A EA034347B1 (ru) 2011-10-26 2012-10-25 Способ инактивации вирусов при получении антител

Country Status (16)

Country Link
US (1) US10634589B2 (ru)
EP (1) EP2771038B1 (ru)
JP (2) JP6526414B2 (ru)
KR (1) KR102091294B1 (ru)
CN (1) CN104136047B (ru)
AU (1) AU2012328753A1 (ru)
BR (1) BR112014010027A2 (ru)
CA (1) CA2853371A1 (ru)
EA (2) EA034347B1 (ru)
ES (1) ES2693508T3 (ru)
HK (1) HK1203423A1 (ru)
IL (1) IL232019A0 (ru)
MX (1) MX361039B (ru)
SG (1) SG11201401739YA (ru)
WO (1) WO2013063298A1 (ru)
ZA (1) ZA201402923B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603956B2 (en) * 2013-12-12 2017-03-28 Paul Newham Dynamic enhanced and diffuse broad spectrum UVC or alternative controlled ionizing radiation source emitters for mobile and fixed placement disinfection of clinical surfaces
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
DK3152317T3 (en) 2014-06-04 2019-04-08 Amgen Inc Methods for Harvesting Mammalian Cell Cultures
WO2016089919A1 (en) 2014-12-01 2016-06-09 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
WO2018083248A1 (en) 2016-11-03 2018-05-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
CN107496950B (zh) * 2017-08-18 2021-02-02 广州市众为生物技术有限公司 一种紫外线照射灭活蛋白溶液中病毒的方法
WO2022024589A1 (ja) 2020-07-27 2022-02-03 国立研究開発法人理化学研究所 感染防止装置及び感染防止方法
US20230287335A1 (en) 2020-07-30 2023-09-14 Amgen Inc. Cell culture media and methods of making and using the same

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
JP3426237B2 (ja) * 1993-05-28 2003-07-14 ニューヨーク ブラッド センター，インコーポレイティド 生物学的組成物の滅菌方法及びこの方法によって生成される製剤
JPH0758031A (ja) 1993-08-18 1995-03-03 Nissin Electric Co Ltd イオン蒸着薄膜形成装置及び該装置を用いた成膜方法
US5925885A (en) * 1996-05-22 1999-07-20 Purepulse Technologies, Inc. Parametric control in pulsed light sterilization of packages and their contents
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
JPH11286453A (ja) * 1998-03-31 1999-10-19 Yoshitomi Pharmaceut Ind Ltd 紫外線照射によるタンパク質含有組成物のウイルス不活化処理方法
GB9821342D0 (en) 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
CN1390112A (zh) 1999-10-08 2003-01-08 布里特斯迈尔公司 同步照射牙齿的装置
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
NZ521392A (en) * 2000-03-23 2004-06-25 Clearant Inc Methods for sterilizing biological materials involving stabilization and irradiation
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
WO2002092138A1 (en) * 2001-05-17 2002-11-21 Purepulse Technologies, Inc. Methods and apparatus relating to treatment systems using light for the treatment of fluid products
US20030064001A1 (en) * 2001-05-17 2003-04-03 Fries William M. System for the decontamination of fluid products using light
EP1404379A2 (en) 2001-05-30 2004-04-07 Gambro, Inc. Viral inactivation process using antioxidant
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
GB0117571D0 (en) * 2001-07-19 2001-09-12 Common Services Agency UV irradiation control
US20030059338A1 (en) 2001-09-24 2003-03-27 Mann David M. Methods for sterilizing biological materials using flavonoid/flavonol stabilizers
US20030064000A1 (en) 2001-09-24 2003-04-03 Wilson Burgess Methods of sterilizing biological mixtures using stabilizer mixtures
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
JP4319979B2 (ja) * 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド タンパク質の非アフィニティ精製
EP1415669A1 (en) * 2002-09-19 2004-05-06 Aventis Behring GmbH Process for sterilization of protein containing biological compositions
KR101304718B1 (ko) 2002-12-20 2013-09-05 암겐 인코포레이티드 미오스타틴을 저해하는 결합제
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
US20050264236A1 (en) 2004-05-25 2005-12-01 Purepulse Technologies, Inc Apparatus and method for use in triggering a flash lamp
US7993580B2 (en) * 2004-08-24 2011-08-09 Baxter International Inc. Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactors
CA2614329C (en) 2005-07-06 2013-01-29 Navigant Biotechnologies, Llc Methods for reducing pathogens in biological samples
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
CA2632519A1 (en) 2005-12-06 2007-07-05 Amgen Inc. Polishing steps used in multi-step protein purification processes
CA2681743A1 (en) * 2007-03-22 2008-09-25 Imclone Llc Stable antibody formulations
ATE506432T2 (de) * 2007-06-15 2011-05-15 Amgen Inc Verfahren zur behandlung von zellkulturmedien für die verwendung in einem bioreaktor
WO2009074867A2 (en) * 2007-12-10 2009-06-18 Novartis Ag Analysis of mixtures including proteins
US7585679B1 (en) * 2008-02-22 2009-09-08 Dionex Corporation Ion chromatography system with flow-delay eluent recycle
US9545438B2 (en) * 2008-02-29 2017-01-17 Universiteit Gent Determination of antigenicity of an inactivated virus
KR20140130512A (ko) * 2008-03-06 2014-11-10 할로자임, 아이엔씨 가용성 히알루로니다아제의 대규모 제조
MX2011002372A (es) * 2008-09-10 2011-04-04 Genentech Inc Composiciones y metodos para la prevencion de la degradacion oxidativa de proteinas.
CN102470251B (zh) 2009-07-09 2015-08-05 皇家飞利浦电子股份有限公司 皮肤辐射设备和方法

Also Published As

Publication number Publication date
CN104136047B (zh) 2018-02-06
JP6526414B2 (ja) 2019-06-05
JP2014533942A (ja) 2014-12-18
EA034347B1 (ru) 2020-01-30
CA2853371A1 (en) 2013-05-02
EP2771038B1 (en) 2018-10-10
CN104136047A (zh) 2014-11-05
AU2012328753A1 (en) 2014-04-24
SG11201401739YA (en) 2014-05-29
EP2771038A1 (en) 2014-09-03
JP2017061462A (ja) 2017-03-30
IL232019A0 (en) 2014-05-28
KR102091294B1 (ko) 2020-04-16
EA201490867A1 (ru) 2014-12-30
ZA201402923B (en) 2015-04-29
HK1203423B (ru) 2018-08-17
HK1203423A1 (en) 2015-10-30
MX2014004880A (es) 2014-09-15
US20140329227A1 (en) 2014-11-06
KR20140079829A (ko) 2014-06-27
ES2693508T3 (es) 2018-12-12
BR112014010027A2 (pt) 2017-04-25
JP6539246B2 (ja) 2019-07-03
MX361039B (es) 2018-11-26
WO2013063298A1 (en) 2013-05-02
US10634589B2 (en) 2020-04-28

Similar Documents

Publication Publication Date Title
EA201992617A1 (ru) Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения
EA201692036A2 (ru) Способ обработки лигноцеллюлозных материалов электронным излучением
EA201390190A1 (ru) Ингибиторы вируса гепатита с
EA201892151A1 (ru) Способ синтеза 2-гидрокси-6-((2-(1-изопропил-1h-пиразол-5-ил)пиридин-3-ил)метокси)бензальдегида
EA201270656A1 (ru) Ингибиторы вируса гепатита с
EA201391152A1 (ru) Ингибиторы вируса гепатита с
EA201101082A1 (ru) Ингибиторы вируса гепатита с
EA201171208A1 (ru) Ингибиторы вируса гепатита с
EA201390856A1 (ru) Инактивация вирусов с применением улучшенного способа растворитель-детергент
MX344268B (es) Proceso para purificacion de proteinas.
EA201190224A1 (ru) Ингибиторы гепатита c, содержащие конденсированные кольца
EA201490893A1 (ru) Переработка биомассы
EA201591786A1 (ru) Монотерапия gla для применения в лечении рака
EA200870164A1 (ru) Лечение вирусного гепатита
EA201270622A1 (ru) Ингибиторы вируса гепатита с
EA201370017A1 (ru) Ингибиторы вируса гепатита с
EP2267119A4 (en) PROCESS FOR VIRUS ENRICHMENT
BR112013008813A2 (pt) instalação de tratamento de resíduos e método de tratar resíduos contendo lama dessecada
EA201490688A1 (ru) 2-тиопиримидиноны
EA201391685A1 (ru) Ингибиторы вируса гепатита с
MX2013012284A (es) Regimenes de elevacion de dosis del anticuerpo de proteina 10 inducible por interferon gamma (ip-10).
EA201370071A1 (ru) Способы и композиции для лечения рака легких
EA201001749A1 (ru) Способ лечения недифференцированного артрита
EA201370187A1 (ru) Клеточная культуральная среда для уфс воздействия и относящиеся к ней способы
EA201401286A1 (ru) Композиции и способы для лечения синдрома раздраженной толстой кишки с помощью 5-аминосалицилата